logo-loader
HealthPharma & Biotech
viewAdmedus Ltd

Admedus Ltd appoints new CFO as part of move to Brisbane

au_admedus_manufacturing_facility_2_358_57bf8894a2fb7.jpg

Admedus Ltd (ASX:AHZ) has appointed Mark Ziirsen as chief financial officer as the company relocates its corporate services functions to Brisbane.

Ziirsen joins Admedus from Cochlear Ltd (ASX:COH), where he held the role of director of finance and I.T. for Asia Pacific for the past five years.

Wayne Paterson, interim CEO, commented: “Today’s announcement is regarded as both a significant and essential development for Admedus as we scale our business to meet the demands of all of Admedus’ stakeholders.”

Ziirsen will take over from current CFO and company secretary Stephen Mann, who is based in Perth. He will continue to work with Admedus through this transition until the end of the year.

Admedus is developing multiple revenue streams and building a global healthcare company through CardioCel heart valve patch sales, infusion product sales and its immunotherapy programs.

Admedus' flagship product is CardioCel®, a bio-engineered tissue scaffold to repair congenital heart defects, and expanding into the heart valve market.

The company is about to close a 1:9 fully underwritten rights issue to raise $8.3 million priced at $0.33.

The rights issue follows the recently completed placement of $10 million.

 

Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.

Quick facts: Admedus Ltd

Price: 0.064 AUD

ASX:AHZ
Market: ASX
Market Cap: $37.81 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Admedus Ltd named herein, including the promotion by the Company of Admedus Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Admedus CEO in New York to update on recent key milestones

Admedus Ltd (ASX:AHZ) CEO Wayne Paterson visited the Proactive Investors New York studio to update on key milestones the company has achieved in the past few months, including receiving European approval on two of its products.

on 03/17/2019

2 min read